These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27248204)

  • 21. Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug.
    Doeser A; Dickhof G; Reitze M; Uebachs M; Schaub C; Pires NM; Bonifácio MJ; Soares-da-Silva P; Beck H
    Brain; 2015 Feb; 138(Pt 2):371-87. PubMed ID: 25472797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A common reference-based indirect comparison meta-analysis of eslicarbazepine versus lacosamide as add on treatments for focal epilepsy.
    Brigo F; Trinka E; Bragazzi NL; Nardone R; Milan A; Grillo E
    Epilepsy Res; 2016 Nov; 127():12-18. PubMed ID: 27543806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antiepileptic drugs].
    Herranz JL
    Rev Neurol; 2018 Jun; 66(s02):S21-S25. PubMed ID: 29876908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy.
    Moavero R; Santarone ME; Galasso C; Curatolo P
    Brain Dev; 2017 Jun; 39(6):464-469. PubMed ID: 28202262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lacosamide: a new generation in the treatment of epilepsy].
    Gil-Nagel A; Marin H
    Rev Neurol; 2011 Feb; 52(3):159-62. PubMed ID: 21287492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eslicarbazepine acetate: a new option for the treatment of focal epilepsy.
    Mestre T; Ferreira J
    Expert Opin Investig Drugs; 2009 Feb; 18(2):221-9. PubMed ID: 19236268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eslicarbazepine Acetate Monotherapy: A Review in Partial-Onset Seizures.
    Shirley M; Dhillon S
    Drugs; 2016 Apr; 76(6):707-17. PubMed ID: 27055527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. When adverse effects are seen as desirable: Abuse potential of the newer generation antiepileptic drugs.
    Hawkins KL; Gidal BE
    Epilepsy Behav; 2017 Dec; 77():62-72. PubMed ID: 29111505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological management of epilepsy: recent advances and future prospects.
    Johannessen Landmark C; Johannessen SI
    Drugs; 2008; 68(14):1925-39. PubMed ID: 18778117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in adjunctive therapy for epilepsy: focus on sodium channel blockers as third-generation antiepileptic drugs.
    Vohora D; Saraogi P; Yazdani MA; Bhowmik M; Khanam R; Pillai KK
    Drugs Today (Barc); 2010 Apr; 46(4):265-77. PubMed ID: 20502724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eslicarbazepine acetate exposure in pregnant women with epilepsy.
    Costa R; Magalhães LM; Graça J; Vieira M; Gama H; Moreira J; Rocha JF; Soares-da-Silva P
    Seizure; 2018 May; 58():72-74. PubMed ID: 29674237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X).
    Bialer M; Johannessen SI; Levy RH; Perucca E; Tomson T; White HS
    Epilepsy Res; 2010 Dec; 92(2-3):89-124. PubMed ID: 20970964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New antiepileptic drugs].
    Vidaurre J; Herbst J
    Medicina (B Aires); 2019; 79 Suppl 3():48-53. PubMed ID: 31603844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong Kong.
    Fong JK; Chan EL; Leung H; Chan I; Chang RS; Fong GC; Fung EL; Lui CH; Fung BB; Poon TL; Siu D; Wong HT; Yeung E; Yung AW; Zhu CX;
    Hong Kong Med J; 2017 Feb; 23(1):74-88. PubMed ID: 28184017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic variability, efficacy and tolerability of eslicarbazepine acetate-A national approach to the evaluation of therapeutic drug monitoring data and clinical outcome.
    Svendsen T; Brodtkorb E; Reimers A; Molden E; Sætre E; Johannessen SI; Johannessen Landmark C
    Epilepsy Res; 2017 Jan; 129():125-131. PubMed ID: 28043062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New and forthcoming anti-epileptic drugs.
    Prunetti P; Perucca E
    Curr Opin Neurol; 2011 Apr; 24(2):159-64. PubMed ID: 21301338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New possibilities of pharmacotherapy of epilepsy: eslicarbazepine acetate in treatment of focal epilepsy].
    Zhydkova IA; Karlov VA; Vlasov PN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(4):140-145. PubMed ID: 29863708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conversion to eslicarbazepine acetate monotherapy: A pooled analysis of 2 phase III studies.
    Sperling MR; French J; Jacobson MP; Pazdera L; Gough M; Cheng H; Grinnell T; Blum D;
    Neurology; 2016 Mar; 86(12):1095-102. PubMed ID: 26911639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical management of refractory epilepsy--practical treatment with novel antiepileptic drugs.
    Ben-Menachem E
    Epilepsia; 2014 Jan; 55 Suppl 1():3-8. PubMed ID: 24400690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eslicarbazepine acetate for partial-onset seizures.
    Rauchenzauner M; Luef G
    Expert Rev Neurother; 2011 Dec; 11(12):1673-81. PubMed ID: 22091592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.